Remus Pharma Live Share Price Today, Share Analysis and Chart

Name: Remus Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Remus Pharmaceuticals Ltd.
Rating: 1.50225
Author: Trendlyne DVM scores

Iran war impact

Based on the available corporate filings and financial reports through March 2026, the impact of the Middle East conflict on Remus Pharmaceuticals Ltd. (REMUS) is analyzed as follows: ##### Overall Impact: Negative to Moderate Remus Pharmaceutica...

635.00 18.50 (3.00%)

44.27% Fall from 52W High

2,800

NSE Volume

NSE 07 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Expensive Valuation

- / 100

Technically Neutral

37.6 / 100

No estimates available

Remus Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Remus Pharma Live Share Price Today, Share Analysis and Chart

Based on the available corporate filings and financial reports through March 2026, the impact of the Middle East conflict on Remus Pharmaceuticals Ltd. (REMUS) is analyzed as follows: ##### Overall Impact: Negative to Moderate Remus Pharmaceutica...

44.27% Fall from 52W High

SWOT Analysis

Remus Pharma Live Price Chart